Product
SPH3127 + Valsartan
Aliases
SPH3127+valsartan matching placebo
1 clinical trial
1 indication
Indication
Diabetic NephropathyClinical trial
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Dose-finding Phase 2 Clinical Study to Evaluate the Efficacy and Safety of SPH3127 Tablets in the Treatment of Diabetic Kidney DiseaseStatus: Recruiting, Estimated PCD: 2024-09-30